Previous 10 | Next 10 |
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31, 2023. These results are unaudited, subject to the comple...
2024-01-08 14:54:36 ET More on Markets Cathie Wood: Probability is very high that a Spot Bitcoin ETF will be approved this week Market returns are broadening out from the Magnificent 7 - Principal Financial Group Real Estate is the top performing sector since the mar...
NEW YORK, NY / ACCESSWIRE / December 6, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cutera, Inc. ("Cutera" or "the Company") (NASDAQ:CUTR). Investors who purchased Cutera securities prior to February 16, 2021, and continue to hold to...
2023-12-04 10:02:05 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: Ocular Therapeutix, EyePoint Pharmaceuticals among healthcare movers
2023-11-17 02:15:17 ET More on Cutera Cutera: Consider Both Financial Outlook And New CEO Appointment (Rating Upgrade) Cutera stock rallies amid SEC filing on Q3 inventory issues, revenue results Cutera Q3 2023 Earnings Preview Seeking Alpha’s Qu...
2023-11-16 22:53:14 ET Summary The Russell 2000 had a "Power Day" with a return of 5.48%, leading some to speculate that the bottom is in for small and microcaps. Power Days, where the index returns 5% or higher in a single day, are rare and tend to occur in clusters. Historic...
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Stephana Patton, who joined Cutera on November 13, 2023, as the Chief Legal Officer will receive a grant of inducement awards. The i...
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“...
2023-11-14 11:53:07 ET More on Cutera Cutera, Inc. (CUTR) Q3 2023 Earnings Call Transcript Cutera: Consider Both Financial Outlook And New CEO Appointment (Rating Upgrade) Cutera Q3 2023 Earnings Preview Cutera shares rise 18% as CEO, CFO buy $346K in s...
2023-11-14 10:04:00 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
News, Short Squeeze, Breakout and More Instantly...
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2024. Consolidated revenue for the first quarter of 2024 of $38.8 million. ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024. Th...